Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "patents"

95 News Found

Granules India chooses Veeam to protect digital business
Digitisation | May 30, 2022

Granules India chooses Veeam to protect digital business

Pharmaceutical manufacturer uses Veeam solutions to accelerate mission-critical backups by 95% and restore data in minutes, not hours


Johnson & Johnson and Momenta Pharmaceuticals file lawsuit against NATCO Pharma
News | May 25, 2022

Johnson & Johnson and Momenta Pharmaceuticals file lawsuit against NATCO Pharma

This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan


BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
Biotech | May 17, 2022

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI


WHO and MPP announce agreement with NIH for Covid-19 health technologies
Public Health | May 13, 2022

WHO and MPP announce agreement with NIH for Covid-19 health technologies

The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries


We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech
interviews | April 22, 2022

We continue to invest in R&D and new product development: Anish Bafna, CEO & MD, Healthium Medtech

Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans


X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery
News | March 30, 2022

X-Chem’s Noor Shaker awarded for achievements in AI for drug discovery

Shaker is one of six receiving an individual award, which recognizes people, organizations and products bringing AI to life and applying it to solve real problems


USFDA clears Niramai's breast thermography device
News | March 14, 2022

USFDA clears Niramai's breast thermography device

The SMILE-100 System is a breast thermography device that helps healthcare personnel review, measure and analyze thermally significant indications in the breast region


Alkido Pharma and Cedars-Sinai enter Master Collaboration Agreement
Biotech | March 09, 2022

Alkido Pharma and Cedars-Sinai enter Master Collaboration Agreement

Cedars-Sinai Technology Ventures has had 114 patents issued for the fiscal year 2021 and has 511 active technologies under development, as of July 2021


NATCO launches first generic version of Revlimid in the US
Drug Approval | March 07, 2022

NATCO launches first generic version of Revlimid in the US

NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene


AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer
People | March 07, 2022

AnchorDx Appoints Dr. Marina Bibikova as Chief Scientific Officer

Dr. Bibikova is an international leader with over 25 years of experience in genomics industry